AI-Derived Electronic Tumor Marker (e19-9) Can Measure Treatment Response and Outcomes in CA19-9 Non-Producers with Pancreatic Ductal Adenocarcinoma
Year: 2025
Type: preprint
Study design: Observational Study
Source: Research Square
Authors: Anai Kothari, Sam Thalji, Mohammed Aldakkak, Gopika SenthilKumar, Mouloud Belbahri, Tahseen Shaik, Taylor Jaraczewski, Jennifer Merrill, Adhitya Ramamurthi, Anjishnu Banerjee, Bradley Taylor, Mandana Kamgar, Ben George, Beth Erickson, William Hall, Nikki Lytle, Yongwoo Seo, Kathleen Christians, Callisia Clarke, Douglas Evans, Susan Tsai
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4406163910
